HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ryan Nelson

Editor-in-Chief, Medtech Insight, HBW Insight

Washington, D.C.

Ryan has been covering the medical device and consumer health, wellness and beauty sectors since 2004, first as a reporter for Gray Sheet, where he covered beats including Capitol Hill, international and emerging technology, and then as managing editor of Rose Sheet. In his current role, he oversees and heads up strategy for their successor publications Medtech Insight and HBW Insight. He also manages and contributes regularly to HBW Insight’s Beauty channel with a focus on regulatory, policy and legal issues and has moderated related panels at industry events. Ryan has a growing role in developing podcasts, new features, “deep dive” article series, and infographics across teams and publications. Off the job, he enjoys spending time with his wife Katie, son Finn and daughter Maggie in Alexandria, VA, a DC suburb.

Latest From Ryan Nelson

Ulta Beauty Leadership Offers 2023 Holiday Outlook, AI Update In Q3 Earnings Call

The US’ biggest beauty retailer is targeting fiscal 2023 net sales between $11.1bn and $11.15bn, with comparable sales growth of 5% to 5.5%, and is optimistic about 2024 and longer-term strategies. CEO David Kimbell addressed analyst questions on the 2023 holiday season, AI and other points of interest during the firm’s third-quarter earnings call.

Sales & Earnings Retail

EU High Court Is ‘Indifferent To Modern Values’; Reactions To Cosmetic Ingredient Animal-Testing Decision

The Cosmetic Products Regulation’s “once groundbreaking” ban is now worthless, says PETA, which supported Symrise in two cases challenging animal testing required by the European Chemicals Agency for cosmetics-only ingredients under REACH. Cruelty Free Europe, the European Federation for Cosmetic Ingredients, and Unilever also intervened on Symrise’s behalf.

Regulation Animal Testing

NAD’s Laura Brett Looks At 2024: ‘Clean Beauty,’ Influencers, Health Claims, Dark Patterns And AI

Brett discusses the BBB National Programs division’s plans for beauty and wellness activities in the new year, the ongoing challenge of getting influencers and brands to disclose material relationships, the FTC’s Health Products Compliance Guidance, and more in a 28 November interview with HBW Insight.

Advertising, Marketing & Sales Regulation

NARB Agrees: Jukebox Is Natural Soap, But That Doesn’t Make Competing Products ‘Detergents’

Unilever prevails in its case against Jukebox soap maker Dr. Squatch, which claims it markets “really, real soap” made through the cold process saponification method, whereas most other purported soaps are synthetic detergents. The National Advertising Review Board panel has upheld the National Advertising Division’s decision finding such claims misleading even if technically true.

Advertising, Marketing & Sales Regulation

Hair-Relaxer Litigation May Proceed In Illinois Federal Court, Judge Rules

US district judge Mary Rowland decided not to throw out the majority of plaintiffs’ claims against L’Oreal, Revlon, SoftSheen-Carson and other hair-relaxer marketers on 13 November. She says plaintiffs have sufficiently pleaded at this stage that defendants’ negligence resulted in their unknowingly using toxic chemical straightening products on their hair, leading to cancers or other injuries.

Legal Issues Cosmetic Ingredients

Cosmetics News: Natura Sells The Body Shop; e.l.f. Launches Roblox Experience; DIY Nailbot STEM Kit; More

Natura says its sale of The Body Shop to international private equity group Aurelius – following its divestiture of Aesop to L’Oreal in a deal that closed in August – is another step toward simplifying operations and refocusing on strategic priorities. More cosmetics news.

Advertising, Marketing & Sales Deals
See All
UsernamePublicRestriction

Register